Stereotaxis (STXS) Investor presentation summary

Technology and innovation

• Offers unique robotic solutions for minimally invasive endovascular surgery, leveraging robotic magnetic navigation (RMN) for precise catheter control and improved safety and reach in complex anatomies.

• GenesisX robot enables rapid installation and compatibility with various x-ray systems, reducing adoption barriers and expanding market opportunities.

• Proprietary MAGIC ablation and mapping catheters, along with the Synchrony digital operating room system, drive innovation and recurring revenue.

• Acquisition of Robocath and development of EMAGIN vascular devices expand the platform into interventional cardiology and neurointervention.

• Digital ecosystem initiatives focus on automation, AI, and enhanced connectivity for operating rooms.

Market presence and growth

• Only robotic technology in the $16B+ electrophysiology market, with a total addressable market exceeding $30B.

• Over 100 systems installed in more than 20 countries, treating 150,000+ patients globally.

• Revenue grew 20% year-over-year to $32M in 2025, with projections for continued growth driven by new product launches and expanded indications.

• Multi-specialty platform targets electrophysiology, interventional cardiology, and neurointervention, each representing multi-billion dollar opportunities.

• Multiple independent and synergistic drivers support significant revenue acceleration and margin expansion.

Clinical and operational impact

• RMN technology delivers 1mm/1° precision, enabling navigation through complex anatomy and reducing patient risk.

• Clinical data shows 72% fewer major complications, 36% less radiation exposure, and improved short- and long-term efficacy compared to manual procedures.

• Over 500 publications validate clinical value and real-world impact.

• Robotic approach enhances physician safety, reduces occupational hazards, and democratizes procedural skill.

• Enables advanced care for complex arrhythmias and congenital heart disease, expanding treatment options.